(March 27, 2020 / JNS) Intel Israel announced a donation of NIS 1.25 million (about $339,114) on Monday to the Rambam Health Care Campus in Haifa to be used for the purchase of a coronavirus testing machine, reported the website NoCamels.
The Genomic STARlet by Hamilton Robotics produces and extracts genetic material from respiratory samples taken from people believed to have COVID-19, said Rambam’s general-director Michael Halbertal.
The automated machine will increase the number of coronavirus tests that can be processed, which then boost the capability of detection and treatment. The hospital will also receive two systems that can detect the presence of the virus, according to NoCamels.
“With these three devices, we will be able to greatly increase the number of tests performed in the laboratory, while maintaining uncompromising quality,” said Halbertal. “The Rambam Hospital and Intel have a long history of collaborations that directly influenced the hospital’s capabilities and our ability to help patients. This time of current crisis is no different.”
Intel Israel said in a statement: “We are in challenging times that demand social responsibility and unity … including that of the business sector. Intel Israel’s management and employees see great importance in the social responsibility of helping to deal with the coronavirus crisis affecting us these days.”
The number of Israelis infected with COVID-19 stood at 3,035 as of Friday, according to the Ministry of Health.
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.